BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15452453)

  • 1. Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre.
    Patócs A; Karádi E; Tóth M; Varga I; Szücs N; Balogh K; Majnik J; Gláz E; Rácz K
    Eur J Cancer Prev; 2004 Oct; 13(5):403-9. PubMed ID: 15452453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
    Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Brouwers FM; Abu-Asab MS; Worrell RA; Walther MM; Elkahloun AG; Goldstein DS; Cleary S; Eisenhofer G
    Eur J Endocrinol; 2005 Oct; 153(4):551-63. PubMed ID: 16189177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
    Dahia PL; Toledo SP; Mulligan LM; Maher ER; Grossman AB; Eng C
    Cancer Res; 1997 Jan; 57(2):310-3. PubMed ID: 9000574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
    Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.
    Opocher G; Schiavi F; Vettori A; Pampinella F; Vitiello L; Calderan A; Vianello B; Murgia A; Martella M; Taccaliti A; Mantero F; Mostacciuolo ML
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):707-15. PubMed ID: 14974911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
    Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
    Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
    J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.
    van der Harst E; de Krijger RR; Dinjens WN; Weeks LE; Bonjer HJ; Bruining HA; Lamberts SW; Koper JW
    Int J Cancer; 1998 Jul; 77(3):337-40. PubMed ID: 9663592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
    Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
    World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
    Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
    Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.
    Hofstra RM; Stelwagen T; Stulp RP; de Jong D; Hulsbeek M; Kamsteeg EJ; van den Berg A; Landsvater RM; Vermey A; Molenaar WM; Lips CJ; Buys CH
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2881-4. PubMed ID: 8768845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.